Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension (BOSAPAH)

This study has been completed.
Sponsor:
Collaborator:
Actelion
Information provided by (Responsible Party):
Robert P Baughman, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT00581607
First received: December 26, 2007
Last updated: April 10, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
No publications provided by University of Cincinnati

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):